Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Development of Kits for 99mtc Radiopharmaceuticals for Infection Imaging

Development of Kits for 99mtc Radiopharmaceuticals for Infection Imaging

International Atomic Energy Agency

Paperback

Series: IAEA Tecdoc

Business GeneralPhysics

Currently unavailable to order

ISBN10: 9201113048
ISBN13: 9789201113047
Publisher: International Atomic Energy Agency
Published: Aug 30 2004
Pages: 277
Language: English
Development of Tc-99m labelling strategies can be useful in the preparation of infection imaging agents by laboratories in Member States. With techniques that were developed for the testing of label stability in vitro and in vivo, with the laboratories participating in the project becoming proficient in labelling the chosen molecules with Tc-99m using a variety of techniques, and with in vivo and in vitro quality assurance measurements standardized by all participants and applied, Tc-99m agents were viewed as reliably labelled. Additionally, with the identification of Tc-99m ubiquicidin peptide 2941 as a radiolabelled agent with potential clinical utility, the project has made a major contribution to nuclear medicine by providing the first convenient Tc-99m labelled specific' infection imaging agent.

Also from

International Atomic Energy Agency

View All

Also in

Business General

View All